: Priced at $2.43, this healthcare company is developing innovative cancer treatments.
: Trading around $4.03, this biotech firm has a forward P/E of 3.00. It is a high-growth play with projected 1-year EPS growth of over 150%.
: An energy and engineering firm now positioned as an AI infrastructure powerhouse. Despite high performance, it trades at a 50% PEG discount to its sector.
: Trading near $6.55, Transocean is considered "absurdly cheap" by some Capital.com analysts , with price targets as high as $10 if oil prices remain stable. Value Dividends
: Currently priced at $2.97, Petco is viewed as a turnaround story with a projected EPS growth of 58% over the next year.
Penny stocks carry higher risk but offer the possibility of outsized percentage gains.
